|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Oct―09 |
Baricitinib treatment of extragenital lichen sclerosus caused by COVID-19 vaccine |
Xin Wang, Yuling Shi, Yeqiang Liu |
2 |
[GO] |
2023―Jun―02 |
Teledermatology in the provision of biologics through COVID-19 in a rural dermatology practice-A retrospective review |
Xin Lin Wong, Joshua Alexander Farrell, Andrew Campbell Satchell, Deshan Frank Sebaratnam |
3 |
[GO] |
2023―Feb―18 |
Evaluation of teledermatology during a pandemic: Assessing patient satisfaction, cost evaluation and clinical effectiveness |
Z. M. Low, D. N. Koye, J. Haurat, B. Ioppi, E. Antunes, Timothy N Fazio, et al. (+7) J. Nicolopoulos, C. Dolianitis, A. Howard, B. Radulski, L. Scardamaglia, V. Morgan, J. S. Kern |
4 |
[GO] |
2022―Sep―04 |
Erythema multiforme following vaccination for
SARS-CoV
-2: Report of a case and review of the literature - Secondary Publication |
Yuki Kobyashi, Takeya Adachi, Hiroki Arakawa, Mie Takeuchi, Toyoko Inazumi |
5 |
[GO] |
2022―May―27 |
Optimizing two-stage surgery by expanding single-stage nasal reconstruction in the COVID-19 era |
Ana Suarez-Valle, Luis Rios-Buceta, Miguel Dominguez-Santas, Oscar Muñoz-Marrones, Sonia Bea-Ardebol |
6 |
[GO] |
2021―Nov―24 |
An unusual presentation of pemphigus foliaceus following COVID-19 vaccination |
Angelyn Chen Yin Lua, Felicia Li Ling Ong, Karen Jui Lin Choo, Yi Wei Yeo, Choon Chiat Oh |
7 |
[GO] |
2021―Nov―16 |
Comparison between melanoma diagnostic pathways and access to services for rural versus metropolitan patients during Victoria’s COVID-19 lockdown |
Katrina Tan, Yan Pan, Victoria Mar |
8 |
[GO] |
2021―Nov―09 |
A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination |
Ashod Kherlopian, Cathy Zhao, Ludi Ge, Emily Forward, Gayle Fischer |
9 |
[GO] |
2021―Sep―12 |
Impact of the COVID-19 pandemic on dermatology practice in the Philippines: A cross-sectional study |
Camille Angeles, Czarina Chavez, Hester Lim, Bryan Guevara, Lian Jamisola |
10 |
[GO] |
2021―Aug―16 |
Australian Teledermatology experience during COVID-19 |
Zhi Mei Low, Laura Scardamaglia, Vanessa Morgan, Johannes S Kern |
11 |
[GO] |
2021―Jun―15 |
Impact of COVID-19 on inpatient dermatology consults in an Australian tertiary hospital |
Genevieve Ho, Stephanie C. Blake, Tabrez Sheriff, Benjamin S. Daniel, Dedee F. Murrell |
12 |
[GO] |
2021―May―24 |
Treatment recommendations for patients with vitiligo during COVID-19 |
Michelle Rodrigues, Amit G. Pandya, Iltefat Hamzavi, Khaled Ezzedine, Marcel W. Bekkenk, John E. Harris |
13 |
[GO] |
2021―May―10 |
Sensitisation to antiseptics in Waikato, New Zealand, prior to the coronavirus disease 2019 pandemic |
Ming Yan Lydia Chan, Harriet Cheng, Amanda M. M. Oakley |
14 |
[GO] |
2021―Mar―31 |
SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group |
Charlie Wang, Marius Rademaker, Bruce Tate, Christopher Baker, Peter Foley |
15 |
[GO] |
2021―Feb―20 |
Cutaneous manifestations and dermatological sequelae of Covid-19 infection compared to those from other viruses |
Surabhi Sharma, Edward Raby, Sujith Prasad Kumarasinghe |
16 |
[GO] |
2020―Nov―21 |
Pityriasis rosea-like eruption revealing COVID-19 |
Stefano Veraldi, Maurizio Romagnuolo, Valentina Benzecry |
17 |
[GO] |
2020―Sep―28 |
Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature |
Lula María Nieto-Benito, Elisa Hernández de la Torre-Ruiz, Inmaculada Balaguer-Franch, Ángel Manuel Rosell-Díaz, Ana Mateos-Mayo, Alejandro Herrero-Sanchez, et al. (+9) Clara Lacasta-Plasín, Paloma García-Piqueras, Lucía Barchino-Ortiz, Marta Bergón-Sendín, Ana Pulido-Pérez, Ofelia Baniandrés-Rodríguez, Enrique Rodriguez-Lomba, Irene Molina-Lopez, Ricardo Suárez-Fernandez |
18 |
[GO] |
2020―Aug―28 |
Acro-ischemic lesions associated with extremely elevated D-Dimer in a child during the COVID-19 pandemic |
Miguel Fernando García-Gil, Juan Monte Serrano, Mar García García, José Alfonso Pascual-del-Riquelme, Mariano Ara-Martín |
19 |
[GO] |
2020―Aug―20 |
Guidance on infection control and plume management with Laser and Energy-Based Devices taking into consideration COVID-19 |
John R Sullivan, Marius Rademaker, Greg Goodman, Philip Bekhor, Firas Al-Niaimi |
20 |
[GO] |
2020―Aug―20 |
SDRIFE-like rash associated with COVID-19, clinicopathological correlation |
Pablo Chicharro, Pedro Rodríguez-Jiménez, Ester Muñoz-Aceituno, Diego De Argila, Patricia Muñoz-Hernández, Mar Llamas-Velasco |
21 |
[GO] |
2020―Aug―11 |
Re Facial aesthetic injections in clinical practice: Pretreatment and post-treatment consensus recommendations to minimise adverse outcome Region-specific changes in line with the Covid-19 pandemic |
Greg J Goodman, Steven Liew, Peter Callan, Sarah Hart, Naveen Somia, John Sullivan, Izolda Heydenrych |
22 |
[GO] |
2020―Aug―05 |
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center |
Federico Diotallevi, Oriana Simonetti, Giulia Radi, Anna Campanati, Valerio Brisigotti, Corrado Tagliati, et al. (+3) Giulio Rizzetto, Emanuela Martina, Annamaria Offidani |
23 |
[GO] |
2020―Jul―16 |
Necrotic acral lesions and lung failure in a fatal case of COVID-19 |
Antonella Tammaro, Camilla Chello, Alvise Sernicola, Francesca Magri, Ganiyat Adenike Ralitsa Adebanjo, Francesca Romana Parisella, et al. (+4) Alessandra Scarabello, Aldo Pezzuto, Sergio Ramirez-Estrada, Jordi Rello |
24 |
[GO] |
2020―May―15 |
Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic |
Eleonora Cinelli, Matteo Megna, Adriana Di Guida, Vincenzo Greco, Maria Carmela Annunziata, Gabriella Fabbrocini |
25 |
[GO] |
2020―Apr―21 |
Response of a tertiary dermatology department to COVID-19 |
Samuel Der Sarkissian, Angelica Tjokrowidjaja, Deshan F Sebaratnam, Monisha Gupta |
26 |
[GO] |
2020―Apr―07 |
COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement |
Charlie Wang, Marius Rademaker, Christopher Baker, Peter Foley |
27 |
[GO] |
2020―Mar―27 |
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases |
Marius Rademaker, Christopher Baker, Peter Foley, John Sullivan, Charlie Wang |